Table 1 Clinical and Physiologic Characteristics in Patients with HP
Characteristics | All patients (N = 261) |
|---|---|
Demographics | |
 Age of diagnosis, y | 57 ± 14 |
 Female sex | 157 (60.1) |
 Race | |
  Caucasian/White | 217 (83.1) |
  African American/Black | 29 (11.1) |
  American Indian | 1 (0.3) |
  Multiracial | 1 (0.3) |
  Other | 6 (2.3) |
  Not reported | 7 (2.7) |
 Cigarette smoking status | |
  Nonsmoker | 142 (54.4) |
  Former/Current Smoker | 94 (36.0) |
  Not reported | 23 (8.8) |
 Exposure | |
  Identified IA | 181 (69.3) |
  Unidentified IA | 80 (30.7) |
 Type of Exposure | |
  Mold | 78 (43.1) |
  Bird | 47 (26) |
  Hot tub | 3 (1.7) |
  Dust | 14 (7.7) |
  Farmer’s lung | 13 (7.2) |
  Occupational | 10 (5.5) |
  Drugs | 11 (6.1) |
 Positive ANA | 50 (19.2) |
 Pulmonary function tests, % predicted | |
  TLC | 71 ± 21 |
  RV | 73 ± 36 |
  FVC | 68 ± 22 |
  FEV1 | 67 ± 22 |
  FEV1/FVC | 78 ± 10 |
  DLCO | 60 ± 25 |
 CT findings | 89 (34.1) |
  Mosaic attenuation | 39 (14.9) |
  Centrilobular nodules | 16 (6.1) |
  Bronchiectasis | 38 (14.6) |
  Fibrosis | 11 (4.2) |
  Nonspecific imaging | 12 (4.6) |
 Biopsy obtained | 120 (49.4) |
  VATS | 92 (76.7) |
  Classical TBB | 13 (10.8) |
  Both | 15 (12.5) |